Gram Research analysis of a 2026 rat study found that injecting gastrin-releasing peptide, a gut-derived signal, into two brain regions reduced how much hungry rats ate of regular chow, but did not reduce their intake of a sweet, fatty treat. The finding suggests this brain signal may curb hunger-driven eating rather than cravings for tasty food.
Researchers tested whether a gut-derived signal called gastrin-releasing peptide (GRP) could change how much rats ate when they were hungry or when they had access to a tasty, sweet-fat diet. The study, published in Brain Research in 2026, delivered GRP directly into two brain areas linked to eating: the paraventricular nucleus of the hypothalamus and the nucleus accumbens. When food-restricted rats received GRP, they ate noticeably less regular chow, and their movement was not affected, so the drop in eating did not appear to come from sluggishness. Rats that were not hungry and were given a sweetened-fat diet did not eat less overall, although the first 30 minutes showed a possible early effect in one brain area. According to research reviewed by Gram, the signal seems to target hunger-driven eating more than the pull of rewarding food. These results come from animal studies and do not yet show how GRP would work in people.
Key Statistics
A 2026 study in male Sprague-Dawley rats published in Brain Research found that gastrin-releasing peptide delivered into the brain at doses up to 300 nanograms per side significantly reduced how much food-restricted rats ate of regular chow during 2-hour sessions.
In the same 2026 rat study, gastrin-releasing peptide did not change how much well-fed rats ate of a sweetened-fat diet across the full 2-hour session, although an exploratory analysis of the first 30 minutes hinted at a limited early effect.
The 2026 Brain Research study measured movement alongside eating and found no significant change in locomotor activity in rats given gastrin-releasing peptide, suggesting the reduced food intake was not caused by sluggishness.
The Quick Take
- What they studied: Scientists wanted to know whether a gut signal called gastrin-releasing peptide, which helps digestion, could also influence eating by acting on two brain regions: one tied to hunger and one tied to pleasure from tasty food.
- Who participated: The study used male Sprague-Dawley rats, a common laboratory strain. Some rats were food-restricted to make them hungry, and others had normal access to food. The exact number of rats was not stated in the summary provided.
- Key finding: When hungry rats received GRP directly into the brain, they ate less regular chow over a 2-hour session, with doses up to 300 nanograms per side. The same signal did not reduce how much well-fed rats ate of a sweet, fatty diet across the full 2 hours.
- What it means for you: This research is at an early stage and was done in rats, so it does not tell you how to eat or what to take. It does add to evidence that gut-brain signals help control hunger, which may matter for future appetite research in people.
The Research Details
Researchers started by placing thin guide tubes, called cannulas, into specific brain areas of male rats. These tubes allowed them to deliver small, measured amounts of GRP directly to the target regions on both sides of the brain. Two areas were studied: the paraventricular nucleus of the hypothalamus, which is involved in sensing energy needs, and the anterior medial nucleus accumbens, which is involved in reward and the appeal of tasty food.
The rats were tested in two different ways. In the first group, rats were food-restricted, meaning they were kept somewhat hungry, and then given regular rat chow during 2-hour sessions after GRP or a control injection. In the second group, rats had normal food access and were offered a sweetened, high-fat diet during similar 2-hour sessions. Researchers also tracked general movement to check whether any change in eating was simply due to the rats being less active.
Because the study compared the same animals under different doses and conditions, it could show cause-and-effect patterns more clearly than a simple observation would. The researchers also ran additional exploratory checks on the first 30 minutes of eating, which helped them look for early effects.
Injecting a substance straight into a specific brain area lets scientists pinpoint where it acts. By comparing hungry rats with well-fed rats, the researchers could tell whether GRP was mainly reducing basic hunger or also reducing the appeal of rewarding food. Measuring movement helps rule out the possibility that rats simply ate less because they were tired or sluggish.
The study design includes controlled comparisons, direct brain targeting, and a check on movement, which are strengths for an animal experiment. However, the summary provided does not state the number of rats per group, and the sample size is unknown from the available text. Findings in rats do not automatically apply to humans, and the early-eating result was labeled exploratory, so it needs confirmation in future studies.
What the Results Show
The main result was clear in hungry rats. When GRP was delivered into either the paraventricular nucleus or the nucleus accumbens, food-restricted rats ate significantly less regular chow during the 2-hour test. This happened across a range of doses, from 0 to 300 nanograms per side, which means the effect was tied to the amount of GRP given.
Importantly, the drop in eating did not come with a change in movement. Researchers measured locomotor activity, which is how much the rats moved around, and found no significant change. This suggests the rats were not simply too sluggish to eat, and that the signal was more likely reducing their drive to eat.
In contrast, rats with normal food access did not eat less of the sweetened, high-fat diet over the full 2-hour session after GRP injection. This suggests that GRP did not broadly reduce interest in tasty, rewarding food when the animals were not hungry.
The researchers did note a possible early effect. In exploratory analyses of the first 30 minutes, GRP injected into the nucleus accumbens seemed to reduce eating of the palatable diet. This pattern was limited and not present across the full session, so it should be viewed as a hint rather than a firm conclusion.
The study also reinforced that the two brain regions tested can both influence eating, depending on the situation. The paraventricular nucleus appeared to be linked with reducing hunger-driven eating, and the nucleus accumbens showed a possible short-term link with reward-driven eating. These separate roles help scientists understand how the brain balances the need for energy with the pleasure of food.
These results are consistent with earlier studies showing that GRP reduces food intake when given through the bloodstream or into the brain’s fluid-filled spaces. Previous work on gut-derived hormones has shown that many of them help reduce eating by signaling fullness or energy balance, and this study adds information about specific brain targets. Together, the findings support the idea that GRP is part of the gut-brain system that controls how much we eat.
This study was done in rats, and the way their brains handle hunger and food rewards may differ from humans. The summary does not report the number of rats in each group, which makes it harder to judge how strong the evidence is. The early-eating effect came from exploratory analysis, meaning it was not the main planned test, so it may not hold up in future research. The study also looked at short sessions of 2 hours, so it does not show what happens over days, weeks, or months. Finally, the study tested direct injections into the brain, which is not a practical way to treat appetite in people.
The Bottom Line
No changes to eating habits or supplement use are supported by this study alone. The evidence is preliminary and comes from animal research with direct brain injections, so confidence in applying these findings to people is low at this stage. The results are most useful as a starting point for further research on whether gut-brain signals like GRP could help regulate appetite. Anyone concerned about hunger or weight should talk with a doctor or registered dietitian rather than acting on this study.
Researchers studying appetite, obesity, and gut-brain communication should pay attention, as should scientists designing future studies on hunger signals. People who simply want to manage everyday eating should not change their habits based on this study. Anyone with an eating disorder, diabetes, or a medical condition affecting appetite should seek personal medical guidance.
Findings from animal studies like this usually take years to move toward human research, and many early ideas never reach clinical use. Any future human studies would first need to confirm safety and effectiveness. Realistically, it may be a long time before this research leads to any practical tool for appetite control.
Frequently Asked Questions
Does gastrin-releasing peptide reduce hunger in humans?
This question has not been answered yet. A 2026 study in rats found that gastrin-releasing peptide injected into two brain regions reduced eating in food-restricted animals, but no human trials were reported. More research is needed before any conclusions about people can be drawn.
What is gastrin-releasing peptide and what does it normally do?
Gastrin-releasing peptide is a signaling molecule released by nerve cells in the stomach and gut. It helps control digestion by triggering gastrin release, supporting pancreatic secretions, and increasing gut movement. Researchers are also studying its role in signaling hunger and fullness to the brain.
Can a gut hormone change cravings for sweet or fatty foods?
A 2026 rat study found that gastrin-releasing peptide reduced eating of regular chow in hungry rats but did not significantly reduce intake of a sweet, fatty diet in well-fed rats over 2 hours. This suggests the signal may mainly affect hunger rather than cravings for rewarding food.
Should I change my diet based on this rat study?
No. This study was done in rats using direct brain injections, which cannot be applied at home. It adds to early research on gut-brain signals controlling appetite. Anyone with concerns about hunger, weight, or eating habits should speak with a doctor or registered dietitian.
Want to Apply This Research?
- Track daily hunger ratings on a simple 1 to 10 scale before meals, along with the approximate amount of food eaten. Logging these two numbers for 2 to 4 weeks can show personal patterns in hunger and eating without making claims about GRP.
- Use the app to notice whether you eat more when truly hungry versus when eating for enjoyment, such as when snacking on sweet or fatty foods. Simply labeling each eating episode as hunger-driven or reward-driven can build awareness that supports healthier choices.
- Review hunger and eating logs monthly to spot trends, such as whether meals are spaced too far apart or whether high-reward foods are often eaten late at night. Share these trends with a healthcare provider during routine visits to guide personalized decisions.
This article summarizes a laboratory study conducted in rats and is intended for general education only. The findings have not been tested in humans and should not be used to make decisions about eating, dieting, supplements, or medical treatment. Consult a qualified healthcare provider or registered dietitian for advice about appetite, weight, or any health condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.